A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in China
Clinical trial NCT05306223 · UNKNOWN
Trial details
- NCT number
- NCT05306223
- Sponsor
- Beijing Chest Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-10
- Primary completion
- 2025-08-08
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.